OW 2025 4 - 7 November 2025

Efficacy of Oral Semaglutide 25 mg in People with Overweight or Obesity and Poor Physical Function

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide (oral)
PHASE 3 (RCT)